The University of Southern California Research Center for Liver Diseases, funded since 1995, has the goal of fostering and facilitating interdisciplinary research in liver and digestive disease. The Center has 41 members and 17 affiliated members. The Biomedical Research Base consists of four major Themes supported by 57 peer-reviewed grants totaling $10.8 million in annual direct costs. These Themes include: a) viral hepatitis and liver cancer; b) liver injury; c) cell biology, signal transduction, and transport; d) metabolism and gene expression. Four core facilities support this Research Base: 1) Administrative Core which oversees the operations and budget of the Center; the Center Director, Associate Director, Executive Committee, Administrator and External Advisory Board oversee the utilization of the cores, the pilot/feasibility program, and the enrichment program (seminar series and annual symposium); a Mathematical-Analysis Modeling and Image Processing Subcore is available to Center members through the Administrative Core; 2) Molecular Biology Core which is divided into three components: a Central Core which provides access to teaching and equipment as well as specialized techniques, a Proteomic Subcore, and a Microarray Subcore; 3) Cell Biology Core which is divided into a Subcellular Organelle Subcore, which provides cell fractionation, specialized preparations (domaine-enriched vesicles, perfused liver), and access to equipment, and a Confocal Microscopy Subcore which provides imaging of live and fixed cells using various platforms including a new ancillary multiphoton confocal microscope; 4) Cell Culture Core which provides isolated and primary cultured rat, mouse and human hepatocytes and various cell lines. The Center supports Pilot Feasibility projects in diverse areas related to the Themes of the Research Base. Current projects including a) studies to define the mechanism of entry and exit and intracellular trafficking of adenovirus in hepatocytes; b) the characterization of tight junctional claudins in intestinal epithelia and their role in regulation of paracellular permeability; c) the mechanism of endotoxin-induced stabilization of TNF mRNA: role of methylation of stabilizing protein; d) examination of the structure-function of the intestinal transporter, PepT1. The USC Research Center for Liver Diseases remains dedicated to attracting, promoting, and supporting research aimed at understanding, preventing, and treating liver and digestive diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK048522-11
Application #
6826550
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (M1))
Program Officer
Podskalny, Judith M,
Project Start
1997-03-01
Project End
2010-02-28
Budget Start
2005-03-04
Budget End
2006-02-28
Support Year
11
Fiscal Year
2005
Total Cost
$1,133,433
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Chang, Huiyi H; Yeh, Jih-Chao; Ichiyama, Ronaldo M et al. (2018) Mapping and neuromodulation of lower urinary tract function using spinal cord stimulation in female rats. Exp Neurol 305:26-32
Chen, Chien-Yu; Chen, Jingyu; He, Lina et al. (2018) PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne) 9:338
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Edman, Maria C; Janga, Srikanth R; Meng, Zhen et al. (2018) Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep 8:11044
Baulies, Anna; Montero, Joan; Matías, Nuria et al. (2018) The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol 14:164-177
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184

Showing the most recent 10 out of 449 publications